Literature DB >> 17034415

Differential effect of auxotrophies on the release of macromolecules by Salmonella enterica vaccine strains.

Holger Loessner1, Anne Endmann, Manfred Rohde, Roy Curtiss, Siegfried Weiss.   

Abstract

Attenuated Salmonella enterica strains have been widely used as live carriers for vaccines and therapeutic molecules. Appropriate attenuation has been introduced into such bacteria for safety reasons and the improvement of strain properties. Here, we compared two strains that were rendered auxotroph for diaminopimelic acid or thymidine monophosphate precursors by deletion of the genes asd or thyA, respectively. Upon removal of the complementing compound from bacterial cultures, both strains quickly lose their property to form colonies. However, while the Deltaasd bacteria lysed almost immediately under such conditions, DeltathyA bacteria remained physically intact during the observation period. As a consequence, the Deltaasd bacteria released their intracellular content such as proteins or plasmids into the supernatant. In contrast, no intracellular component, either proteins or plasmids, could be recovered from the supernatants of DeltathyA bacteria upon depletion of thymidine. Thus, the release of macromolecules from the bacterial carrier occurs as a consequence of appropriate lethal attenuation. This might substitute for sophisticated secretion systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034415     DOI: 10.1111/j.1574-6968.2006.00470.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells.

Authors:  Yong Bai; Hongjian Li; Gia-Phong Vu; Hao Gong; Sean Umamoto; Tianhong Zhou; Sangwei Lu; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-01       Impact factor: 11.205

2.  Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment.

Authors:  Wei Kong; Soo-Young Wanda; Xin Zhang; Wendy Bollen; Steven A Tinge; Kenneth L Roland; Roy Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

3.  Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral Infection.

Authors:  Zenglin Pei; Xiaohong Jiang; Zhu Yang; Xiaoguang Ren; Hao Gong; Michael Reeves; Jingxue Sheng; Yu Wang; Zishu Pan; Fenyong Liu; Jianguo Wu; Sangwei Lu
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

4.  Generation of influenza virus from avian cells infected by Salmonella carrying the viral genome.

Authors:  Xiangmin Zhang; Wei Kong; Soo-Young Wanda; Wei Xin; Praveen Alamuri; Roy Curtiss
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

5.  Optimizing the dynamics of protein expression.

Authors:  Jan-Hendrik Trösemeier; Sophia Rudorf; Holger Loessner; Benjamin Hofner; Andreas Reuter; Thomas Schulenborg; Ina Koch; Isabelle Bekeredjian-Ding; Reinhard Lipowsky; Christel Kamp
Journal:  Sci Rep       Date:  2019-05-17       Impact factor: 4.379

6.  Electron Microscopy Reveals Unexpected Cytoplasm and Envelope Changes during Thymineless Death in Escherichia coli.

Authors:  T V Pritha Rao; Andrei Kuzminov
Journal:  J Bacteriol       Date:  2021-08-09       Impact factor: 3.490

7.  Engineered external guide sequences are highly effective in inhibiting gene expression and replication of hepatitis B virus in cultured cells.

Authors:  Zhigang Zhang; Gia-Phong Vu; Hao Gong; Chuan Xia; Yuan-Chuan Chen; Fenyong Liu; Jianguo Wu; Sangwei Lu
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

8.  Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain.

Authors:  Karen Roos; Esther Werner; Holger Loessner
Journal:  Microb Biotechnol       Date:  2014-12-09       Impact factor: 5.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.